期刊文献+

原发性硬化性胆管炎的诊断与治疗 被引量:2

Diagnosis and treatment of primary sclerosing cholangitis
原文传递
导出
摘要 目的探讨原发性硬化性胆管炎(PSC)的诊断方法和治疗方案。方法回顾性分析1991年1月至2009年8月北京协和医院收治31例PSC患者的临床资料,通过临床表现、辅助检查、手术方法等探讨该病临床病理特点和预后。结果28例患者表现为梗阻性黄疸,20例患者表现为发热,16例患者表现为腹痛;30例患者ALP升高;14例患者自身抗体阳性;15例患者血清肿瘤标志物异常,其中13例患者CA19—9升高(84~5000U/ml)。B超、CT、MRCP、ERCP检查确诊率分别为3/28、2/24、2/18、18/25。19例患者接受药物治疗,仅1例治疗后无明显不适;12例患者接受手术治疗,2例肝移植患者术后疗效较好;11例患者接受内镜治疗,1例患者治疗后无明显不适,其余患者症状有不同程度减轻。结论PSC临床表现多样,以CA19—9升高最常见。影像学检查中ERCP确诊率最高。常规的内、外科治疗只能缓解临床症状,肝移植的远期疗效较好。 Objective To investigate the diagnosis and treatment strategy of primary sclerosing cholangitis (PSC). Methods From January 1991 to August 2009, 31 patients with PSC were treated at the Peking Union Medical College Hospital. A retrospective study was performed based on the clinical data of these patients to evaluate the methods of diagnosis, curative treatment and prognosis. Results Obstructive jaundice, fever and abdominal pain were the main symptoms of PSC, which accounted for 90% (28/31) , 65% (20/31) and 52% ( 16/31 ) , respectively. Thirty patients presented with an elevation of alkaline phosphatase. The positive rate of autoantibody was 45% ( 14/31 ). The positive expression of serum tumor markers of 15 patients was elevated, and 13 of the 15 patients had an elevated expression of CA19-9 (84-5000 U/mL). The diagnostic accuracies of B-mode ultrasound, computed tomography, magnetic resonance cholangiopancreatography, and endoscopic retrograde cholangiopancreatography (ERCP) were 3/28, 2/24, 2/18, 18/25, respectively. Nineteen patients received drug therapy and only one patient had no obvious discomfort after the treatment. Twelve patients received surgical treatment and the prognosis of two patients who underwent liver transplantation was good. Eleven patients received endoscopic treatment, only one patient had no obvious discomfort and the condition of the remaining 10 patients was alleviated after treatment. Conclusions PSC is usually characterized by an elevated expression of CA19-9. ERCP has a high diagnostic accuracy. Conventional treatments can only relieve the symptoms, whereas liver transplantation has a favorable long-term efficacy.
出处 《中华消化外科杂志》 CAS CSCD 2010年第3期197-199,共3页 Chinese Journal of Digestive Surgery
基金 北京市重点学科建设项目(HK100230446)
关键词 原发性硬化性胆管炎 胆汁淤积 诊断 治疗 Primary sclerosing cholangitis Cholestasis Diagnosis Therapy
  • 相关文献

参考文献2

二级参考文献165

  • 1Piero Portincasa,Michele Vacca,Antonio Moschetta,Michele Petruzzelli,Giuseppe Palasciano,Karel J.van Erpecum,Gerard P.van Berge-Henegouwen.Primary sclerosing cholangitis: Updates in diagnosis and therapy[J].World Journal of Gastroenterology,2005,11(1):7-16. 被引量:7
  • 2[46]Bergquist A,Glaumann H,Stal P,Wang GS,Broome U.Biliary dysplasia,cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.J Intern Med 2001;249:69-75
  • 3[47]Fleming KA,Boberg KM,Glaumann H,Bergquist A,Smith D,Clausen OP.Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis.J Hepatol 2001;34:360-365
  • 4[48]Bjornsson E,Chapman RW.Sclerosing cholangitis.Curr Opin Gastroenterol 2003;19:270-275
  • 5[49]Kim WR,Ludwig J,Lindor KD.Variant forms of cholestatic diseases involving small bile ducts in adults.Am J Gastroenterol 2000;95:1130-1138
  • 6[50]Bjornsson E,Boberg KM,Cullen S,Fleming K,Clausen OP,Fausa O,Schrumpf E,Chapman RW.Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.Gut 2002;51:731-735
  • 7[51]Boberg KM,Schrumpf E,Fausa O,Elgjo K,Kolmannskog F,Haaland T,Holter E.Hepatobiliary disease in ulcerative colitis.An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis.Scand J Gastroenterol 1994;29:744-752
  • 8[52]Angulo P,Maor-Kendler Y,Lindor KD.Small-duct primary sclerosing cholangitis:a long-term follow-up study.Hepatology 2002;35:1494-1500
  • 9[53]van Buuren HR,van Hoogstraten HJE,Terkivatan T,Schalm SW,Vleggaar FP.High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis.J Hepatol 2000;33:543-548
  • 10[54]Bjornsson E,Chaff ST,Smyrk TC,Lindor K.Immunoglobulin G4 associated cholangitis:description of an emerging clinical entity based on review of the literature.Hepatology 2007;45:1547-1554

共引文献17

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部